| Mr Robert Stephen Lipp, PHARM D | |
|
1400 W Kenneth Rd, Glendale, CA 91201-1422 | |
| (818) 242-4195 | |
| (818) 247-8593 |
| Full Name | Mr Robert Stephen Lipp |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1400 W Kenneth Rd, Glendale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801141528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH32284 (California) | Primary |
| 1835P1200X | Pharmacist - Pharmacotherapy | RPH32284 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Stephen Lipp, PHARM D 9332 Crystal View Dr, Tujunga, CA 91042-3209 Ph: (818) 353-6973 | Mr Robert Stephen Lipp, PHARM D 1400 W Kenneth Rd, Glendale, CA 91201-1422 Ph: (818) 242-4195 |
News Archive
TWi Pharmaceuticals, Inc., a specialty pharmaceutical company based in Taiwan, today announced its fully owned subsidiary, TWi Biotechnology, Inc. has completed a multinational phase II dose-ranging study of AC-201, an orally available IL-1 Beta modulator, in 259 patients with type II diabetes uncontrolled on up to three oral medications.
Celgene International Sàrl today announced that results from an investigator-initiated phase II study of ABRAXANE, gemcitabine and bevacizumab as first-line treatment in metastatic breast cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.
Yesterday, during a meeting of the Executive Appropriations Committee of the Utah State Legislature, lawmakers unanimously approved $90 million in funding for the Utah Translational Research Building at the University of Utah Huntsman Mental Health Institute.
A common medication that reduces bleeding could be a treatment for bleeding stroke, particularly if administered quickly, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.
Multipotent cells isolated from the human umbilical cord, called mesenchymal stromal cells (hUC-MSCs) have shown promise for use in cell therapy to treat a variety of human diseases. However, intriguing new evidence shows that hUC-MSCs isolated from women with gestational diabetes demonstrate premature aging, poorer cell growth, and altered metabolic function, as reported in an article in Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 4 days ago
Rosemary Kahale, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Central Ave, Glendale, CA 91203 Phone: 818-637-2758 | |
Annie Ahhyun Kim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3943 San Fernando Rd, Glendale, CA 91204 Phone: 818-549-2270 | |
Dr. Linda Kalamkeryan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Stocker St, 105, Glendale, CA 91202 Phone: 818-433-8379 | |
Dr. Jane Kyun Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Anna Arutunyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 E Broadway, Glendale, CA 91205 Phone: 818-547-0170 | |
Dr. Monica Natalia Macias, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Terrace, Glendale, CA 91206 Phone: 818-409-8140 | |
Arash Akmal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3452 Country Club Dr, Glendale, CA 91208 Phone: 310-463-7326 |